Neuronostics, the Bristol-based MedTech company developing a clinically validated digital biomarker platform, has raised £3M in a funding round co-led by Empirical Ventures and The FSE Group. The round also includes participation from British Business Bank’s South West Investment Fund, Ascension Ventures, QantX, New Wave Venture Partners, and Angel Investors Bristol. The equity investment was...
A medtech start-up in the South West that has developed technology which allows faster and more accurate epilepsy diagnoses, has raised £300,000 in seed funding.
Neuronostics, which won last year's HealthTech award at the Tech South West Awards , raised the cash from a group of private investors who are establishing a new venture capital fund called QantX Ventures.
